Medicare Is Spending Lots More On Rx Drugs: Why That’s A Good Thing

Medicare’s cap on out-of-pocket costs helps cancer patients and others taking expensive drugs. With less financial burden, patients can better afford their medications.

Oz’s `Just Be Healthy’ Message To Counter Flu Sparks Controversy

It isn’t wrong to promote healthier living. But misinforming the public on the flu vaccine and downplaying the disease’s impact aren’t in public health’s interest.

As Insurers Drop Obesity Drug Coverage, Access Worsens For Those Most In Need

At least 12% of adults in the U.S. have been prescribed a glucagon‐like peptide‐1 drug for one or multiple indications, but 54% of users report affordability challenges.

Predicting A Continued Disruptive 2026 In Healthcare And The Economy

Significant changes to public health infrastructure, the healthcare system and economy in 2025 won’t end as we flip the calendar. Disruption will continue in 2026.

How Our Own Cells Could Implant The Next Generation Of Nonsurgical Brain Microchips

MIT researchers are using living cells to target diseased brain areas and deliver tiny electronic devices that can modulate brain activity with infrared light.